CHEBI:90962 - Utibron Neohaler

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name Utibron Neohaler ChEBI ID CHEBI:90962 Definition A two-drug mixture consisting of glycopyrronium bromide, a muscarinic antagonist and indacaterol, a β-2 receptor agonist; used for maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease. Stars This entity has been manually annotated by the ChEBI Team. Roles Classification Application(s): bronchodilator agent An agent that causes an increase in the expansion of a bronchus or bronchial tubes. View more via ChEBI Ontology ChEBI Ontology Outgoing Utibron Neohaler (CHEBI:90962) has part indacaterol maleate (CHEBI:68573) Utibron Neohaler (CHEBI:90962) has part ritropirronium bromide (CHEBI:5494) Utibron Neohaler (CHEBI:90962) has role bronchodilator agent (CHEBI:35523) Utibron Neohaler (CHEBI:90962) is a mixture (CHEBI:60004) Synonyms Sources Glycopyrrolate / indacaterol ChemIDplus Glycopyrrolate mixture with indacaterol ChEBI Glycopyrronium bromide / indacaterol ChemIDplus Indacaterol / glycopyrrolate ChemIDplus Indacaterol / glycopyrronium ChemIDplus QVA 149 ChemIDplus QVA149 ChemIDplus Brand Names Sources Glycopyrronium bromide - indacaterol maleate mixt KEGG DRUG Ultibro KEGG DRUG Utibron Neohaler KEGG DRUG Manual Xref Database D10505 KEGG DRUG View more database links Registry Number Type Source 1262431-94-6 CAS Registry Number ChemIDplus Citations Types Sources 23914352 PubMed citation Europe PMC 25691493 PubMed citation Europe PMC Last Modified 18 January 2016